Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and efficacy of long-term treatment with
NPC-12G gel (0.2% sirolimus gel) to angiofibroma and other skin lesions in patients with
tuberous sclerosis complex in the open-label trial.